(MUX) Mutares SE & Co. KGaA - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A2NB650

MUX: Automotive, Wood, Construction, Technology, Consumer Goods, Healthcare

Mutares SE & Co. KGaA is a private equity firm based in Munich, Germany, specializing in investments across various sectors, including automotive and mobility, wood and paper, construction and infrastructure, engineering, consumer goods, technology, and healthcare. The firm focuses on acquiring controlling stakes in small and medium-sized companies with established market positions, primarily targeting Europe, North America, and Asia. It seeks companies with revenues between €100 million and €750 million and EBITDA up to €5 million, aiming for long-term investments with a holding period of three to five years. Mutares also engages in co-investments, platform and add-on acquisitions, and turnaround strategies.

From a technical perspective, the stock (XETRA:MUX) is currently trading near its 20-day SMA of 26.31, with a last price of 26.85. The 50-day SMA is slightly lower at 25.87, while the 200-day SMA stands at 28.69, indicating a potential downtrend in the medium term. The ATR of 0.79 suggests moderate volatility. On the fundamental side, the company has a market cap of 484.56M EUR, with a price-to-book ratio of 0.64 and a negative return on equity of -0.54. The forward P/E of 19.61 indicates market expectations for future earnings growth.

Three-Month Forecast: - Technical Outlook: The stock is likely to test support near the 200-day SMA (28.69) in the coming weeks. If broken, it could trend lower toward the 50-day SMA (25.87). Resistance is expected at the current 20-day SMA (26.31). - Fundamental Outlook: The negative P/E ratio raises concerns about profitability, but the forward P/E of 19.61 suggests investor confidence in a potential turnaround. The low P/B ratio of 0.64 may indicate undervaluation, but the negative RoE of -0.54 highlights ongoing challenges in generating returns from equity. Overall, the stock is likely to remain range-bound with limited upside unless earnings improve.

Additional Sources for MUX Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

MUX Stock Overview

Market Cap in USD 842m
Sector Financial Services
Industry Asset Management
GiC Sub-Industry Asset Management & Custody Banks
IPO / Inception

MUX Stock Ratings

Growth Rating 60.2
Fundamental -16.4
Dividend Rating 73.0
Rel. Strength -22.7
Analysts -
Fair Price Momentum 44.41 EUR
Fair Price DCF -

MUX Dividends

Dividend Yield 12m 6.02%
Yield on Cost 5y 25.91%
Annual Growth 5y 14.87%
Payout Consistency 70.4%

MUX Growth Ratios

Growth Correlation 3m 79%
Growth Correlation 12m -39.7%
Growth Correlation 5y 82.7%
CAGR 5y 36.51%
CAGR/Max DD 5y 0.74
Sharpe Ratio 12m -0.43
Alpha -13.32
Beta 0.428
Volatility 45.85%
Current Volume 54.8k
Average Volume 20d 65.3k
What is the price of MUX stocks?
As of April 29, 2025, the stock is trading at EUR 37.40 with a total of 54,799 shares traded.
Over the past week, the price has changed by +11.81%, over one month by +16.33%, over three months by +44.96% and over the past year by -7.18%.
Is Mutares SE & Co. KGaA a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Mutares SE & Co. KGaA is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -16.39 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MUX as of April 2025 is 44.41. This means that MUX is currently undervalued and has a potential upside of +18.74% (Margin of Safety).
Is MUX a buy, sell or hold?
Mutares SE & Co. KGaA has no consensus analysts rating.
What are the forecast for MUX stock price target?
According to ValueRays Forecast Model, MUX Mutares SE & Co. KGaA will be worth about 48.6 in April 2026. The stock is currently trading at 37.40. This means that the stock has a potential upside of +29.95%.
Issuer Forecast Upside
Wallstreet Target Price 47.5 27%
Analysts Target Price - -
ValueRay Target Price 48.6 29.9%